OTC · Financial Statements
Isracann Biosciences Inc. (ISCNF) Financial Statements
$0.00
OTC: ISCNF
Market Cap $1760
Overview Financials Dividend Isracann Biosciences Inc. most recently reported annual revenue of $0, net profit of $-5.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2018 2019 2020 2021 2022 Revenue $1.0M $0 $0 $0 $0 Operating Profit $-6.0M $-6.0M $-11.0M $-5.0M $-2.0M Net Profit $-7.0M $-10.0M $-24.0M $-25.0M $-5.0M EPS $-0.33 $-0.75 $-0.26 $-0.18 $-0.03 Op Margin -535.5% — — — —
Balance Sheet (USD)
Metric 2018 2019 2020 2021 2022 Total Assets $15.0M $16.0M $28.0M $4.0M $4.0M Total Liabilities $1.0M $1.0M $2.0M $0 $4.0M Cash $8.0M $4.0M $4.0M $2.0M $0 Borrowings $0 $0 $0 $0 $0
Cash Flow (USD)
Metric 2018 2019 2020 2021 2022 Operating Cash Flow $-3.0M $-3.0M $-10.0M $-4.0M $-2.0M Investing Cash Flow $-12.0M $-1.0M $-3.0M $0 $0 Financing Cash Flow $3.0M $10.0M $13.0M $2.0M $0 Net Cash Flow $8.0M $-4.0M $0 $-2.0M $-2.0M Free Cash Flow $-9.0M $-3.0M $-11.0M $-4.0M $-2.0M
Valuation & Return Ratios
Metric Value PEG Ratio 0.00 EV / EBITDA -0.97 FCF Yield -66.46% Quick Ratio 0.38 Interest Coverage -0.17 Return 1Y 0.00% Return 3Y -99.96% Return 5Y -99.99%
Screens featuring this stock